ArticleJournal for immunotherapy of cancer2022

Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab.

Raanan Berger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.